Researchers identify biomarkers of response to treatment in invasive breast cancer

(UNC Lineberger Comprehensive Cancer Center) Researchers report at the San Antonio Breast Cancer Symposium that they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2-positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news